Ligand validation:9KUL

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9KUL_LFA_P_314	28%	88%	0.198	0.895	0.44	0.24	-	-	2	0	75%	0.6
9KUL_LFA_P_310	26%	96%	0.227	0.886	0.18	0.17	-	-	2	0	90%	0.4
9KUL_LFA_C_309	23%	93%	0.223	0.866	0.2	0.26	-	-	1	0	90%	0.4
9KUL_LFA_N_608	18%	86%	0.248	0.889	0.32	0.4	-	-	6	0	70%	0.6
9KUL_LFA_P_315	18%	94%	0.232	0.881	0.23	0.21	-	-	1	0	65%	0.6
9KUL_LFA_A_608	17%	85%	0.248	0.881	0.54	0.21	-	-	5	0	70%	0.6
9KUL_LFA_B_308	17%	92%	0.274	0.877	0.36	0.19	-	-	1	0	85%	0.6
9KUL_LFA_G_104	16%	64%	0.255	0.878	0.91	0.48	1	-	7	0	70%	0.6
9KUL_LFA_A_609	15%	62%	0.248	0.866	0.74	0.73	-	-	5	0	70%	0.6
9KUL_LFA_C_313	14%	90%	0.254	0.855	0.28	0.33	-	-	1	0	75%	0.6
9KUL_LFA_O_301	14%	90%	0.277	0.858	0.32	0.28	-	-	1	0	85%	0.6
9KUL_LFA_T_102	12%	96%	0.281	0.892	0.19	0.16	-	-	0	0	55%	0.6
9KUL_LFA_C_314	11%	93%	0.276	0.855	0.23	0.24	-	-	0	0	65%	0.6
9KUL_LFA_C_307	11%	94%	0.284	0.878	0.26	0.2	-	-	1	0	55%	0.4
9KUL_LFA_P_301	8%	98%	0.306	0.833	0.16	0.13	-	-	0	0	75%	0.4
9KUL_LFA_P_308	8%	91%	0.296	0.854	0.3	0.26	-	-	2	0	55%	0.4
9KUL_LFA_P_312	8%	97%	0.321	0.852	0.18	0.14	-	-	0	0	70%	0.5
9KUL_LFA_O_302	8%	93%	0.305	0.86	0.32	0.16	-	-	0	0	55%	0.6
9KUL_LFA_C_312	8%	96%	0.305	0.855	0.23	0.13	-	-	2	0	55%	0.5
9KUL_LFA_C_310	7%	96%	0.321	0.849	0.21	0.15	-	-	0	0	55%	0.5
9KUL_LFA_P_313	6%	93%	0.312	0.838	0.26	0.23	-	-	2	0	55%	0.5
9KUL_LFA_C_326	6%	98%	0.344	0.829	0.16	0.1	-	-	0	0	75%	0.4
9KUL_LFA_C_311	5%	97%	0.364	0.817	0.2	0.13	-	-	0	0	70%	0.5
9KUL_LFA_P_309	3%	95%	0.375	0.833	0.27	0.15	-	-	0	0	30%	0.4
9KUL_LFA_C_308	2%	95%	0.398	0.779	0.27	0.14	-	-	0	0	30%	0.4
9KUL_LFA_P_311	1%	99%	0.411	0.715	0.15	0.09	-	-	0	0	55%	0.5
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.